Cargando...

Personalized one-two punches for lung cancer

Discovery of individualized therapies to address resistance to tyrosine kinase inhibitors (TKIs) has been hampered by the inability to test drug combinations on patient samples before and after TKI resistance. A recent study published in Science by Crystal et al. describes a methodology for pharmaco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Res
Main Authors: Scarborough, Hannah A, Bunn, Paul A, DeGregori, James
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349242/
https://ncbi.nlm.nih.gov/pubmed/25547118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2014.168
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!